Min Son of Hanol IP & Law says pharmaceutical R&D in South Korea should be enhanced on the introduction of a clearer legal framework that offers improved market protection for new and modified drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback